FFEC
ARRY

First Financial Equity Corporation’s Array Biopharma Inc ARRY Stock Holding History

First Financial Equity Corporation’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$99K Buy
+10,872
New +$116K 0.02% 431

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

First Financial Equity Corporation's ARRY Position: Q1 2017 in Review

First Financial Equity Corporation opened a new position in Array Biopharma Inc (ARRY) in Q1 2017: 10,872 shares worth $99K. The stake represents 0.02% of the portfolio and ranks #431 among its holdings.

187 funds tracked by Wall St. Rank hold ARRY as of Q1 2017.

  • First Financial Equity Corporation held 10,872 shares of Array Biopharma Inc worth $99K as of Q1 2017.
  • Array Biopharma Inc was a new First Financial Equity Corporation position in Q1 2017.
  • Array Biopharma Inc made up 0.02% of First Financial Equity Corporation's portfolio in Q1 2017, its #431 holding.
  • 187 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2017.

Based on First Financial Equity Corporation's 13F filing for Q1 2017, filed 16 May 2017.